Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Teva
US Department of Justice
Colorcon
Accenture
Cantor Fitzgerald
Argus Health
Harvard Business School

Generated: May 20, 2018

DrugPatentWatch Database Preview

HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Hydrocodone Bitartrate And Chlorpheniramine Maleate, and when can generic versions of Hydrocodone Bitartrate And Chlorpheniramine Maleate launch?

Hydrocodone Bitartrate And Chlorpheniramine Maleate is a drug marketed by Acella Pharms Llc and Tris Pharma Inc and is included in two NDAs.

The generic ingredient in HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE is chlorpheniramine maleate; hydrocodone bitartrate. There are twenty-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the chlorpheniramine maleate; hydrocodone bitartrate profile page.
Summary for HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE
Drug patent expirations by year for HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE

US Patents and Regulatory Information for HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acella Pharms Llc HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE chlorpheniramine maleate; hydrocodone bitartrate SOLUTION;ORAL 206891-001 Jun 9, 2017 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Tris Pharma Inc HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE chlorpheniramine maleate; hydrocodone bitartrate SOLUTION;ORAL 206438-001 Jan 27, 2015 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Baxter
AstraZeneca
QuintilesIMS
Teva
Deloitte
Johnson and Johnson
McKinsey
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.